Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), will present at the 43rd Annual J.P. Morgan Healthcare ...

Hold Biocon 320-put option as stock may drop to ₹350, with potential for premium increase. Contact [email protected] ...

Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement.

Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.

Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...

MUMBAI: Indian shares rose on Tuesday, led by a rally in energy stocks after a brokerage upgraded ONGC and as Reliance recovered some of its losses from the previous session. The Nifty 50 gained 0.39% ...

Microsoft CEO Satya Nadella announces a $3 billion investment in India's cloud and AI infrastructure, including new data ...

Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...

Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with ...

On Tuesday, 2624 stocks advanced, 1355 declined and 107 remained unchanged, with an advance decline ratio of 1.93x on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader ...

Indian shares rose on Tuesday, led by a rally in energy stocks after a brokerage upgraded ONGC and as Reliance recovered some ...

Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.